title: Thrombocytopenia, INR prolongation and fall in fibrinogen under daptomycin.
authors: B
authors: B
authors: Hartmann
authors: S
authors: S
authors: Maus
authors: F
authors: F
authors: Keller
authors: L
authors: L
authors: Rothermund
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001372:Aza Compounds / Q000627:therapeutic use; D017576:Daptomycin / Q000009:adverse effects* / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D005340:Fibrinogen / Q000378:metabolism*; D024841:Fluoroquinolones; D006801:Humans; D019934:International Normalized Ratio / Q000379:methods; D008297:Male; D008875:Middle Aged; D000077266:Moxifloxacin; D011804:Quinolines / Q000627:therapeutic use; D006435:Renal Dialysis; D013203:Staphylococcal Infections / Q000188:drug therapy; D013212:Staphylococcus epidermidis / Q000302:isolation & purification; D013921:Thrombocytopenia / Q000097:blood* / Q000188:drug therapy*; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D014640:Vancomycin; D005340:Fibrinogen; D017576:Daptomycin; D000077266:Moxifloxacin